ArticleBlood advances2018

Bye AP, Unsworth AJ, Desborough MJ, et al. Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.